Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myocardial connective tissue alterations.

J B Caulfield1, P E Wolkowicz

  • 1University of Alabama, Department of Pathology, Birmingham 35294.

Toxicologic Pathology
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quercetin induced tissue-type plasminogen activator expression is mediated through Sp1 and p38 mitogen-activated protein kinase in human endothelial cells.

Journal of thrombosis and haemostasis : JTH·2008
Same author

31P-magnetic resonance spectroscopy studies of cardiac transplant patients at rest.

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance·2001
Same author

Spontaneous coronary artery dissection associated with cocaine use: a case report and brief review.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2001
Same author

Identification of a 251-bp fragment of the PAI-1 gene promoter that mediates the ethanol-induced suppression of PAI-1 expression.

Alcoholism, clinical and experimental research·2001
Same author

Stereoselective synthesis of a conformationally defined cyclohexyl carnitine analogue that binds CPT-1 with high affinity.

Bioorganic & medicinal chemistry·1999
Same author

2-Tetradecylglycidic acid, an inhibitor of carnitine palmitoyltransferase-1, induces myocardial hypertrophy via the AT1 receptor.

Journal of molecular and cellular cardiology·1999
Same journal

Comparison of Standard Clinical Pathology Parameter Values in Fasted and Fed Rats and Non-human Primates.

Toxicologic pathology·2026
Same journal

Time-Dependent Autolysis in Ex Vivo-Maintained Rat Tissue in Saline: A Descriptive Study and Practical Guidance for Histopathologic Assessment.

Toxicologic pathology·2026
Same journal

New Approach Methodologies (NAMs) for Carcinogenicity Evaluation.

Toxicologic pathology·2026
Same journal

2025 International Academy of Toxicologic Pathology (IATP) Satellite Symposium: Pathology Working Groups (PWGs) in Toxicologic Pathology.

Toxicologic pathology·2026
Same journal

Toxicologic Pathology Forum*: Opportunities and Challenges in the Use of Artificial Intelligence in Nonclinical Toxicologic Histopathology Evaluations.

Toxicologic pathology·2026
Same journal

New Modalities and Carcinogenicity Assessment.

Toxicologic pathology·2026
See all related articles

Cardiac collagen matrix damage, caused by ischemia or toxins, leads to ventricular dilatation. This damage is slow to repair, explaining persistent heart dilation in various human diseases.

Area of Science:

  • Cardiovascular Biology
  • Biomedical Engineering

Background:

  • The heart contains a complex collagen network crucial for its structural integrity.
  • This collagen matrix is organized hierarchically from nano- to micron-scale fibrils and fibers.

Purpose of the Study:

  • To investigate the impact of collagen matrix disruption on cardiac structure and function.
  • To explore the repair mechanisms and timelines of the cardiac collagen network.

Main Methods:

  • Induction of collagen loss in animal models using ischemia (coronary artery ligation) and chemical agents (adriamycin, oxidizing glutathione).
  • Observation of structural changes like ventricular bulging and dilatation.
  • Assessment of collagen matrix repair and fibrosis over time.

Main Results:

Related Experiment Videos

  • Ischemia-induced collagen loss caused rapid ventricular bulging.
  • Chemical induction of collagen loss resulted in persistent ventricular dilatation for at least 6 months.
  • Evidence of collagen replacement and fibrosis was observed after 6 months, indicating slow repair.

Conclusions:

  • Disruption of the cardiac collagen matrix can lead to persistent ventricular dilatation, mirroring conditions observed in human heart diseases.
  • The slow repair of the collagen matrix in animal models provides a potential explanation for prolonged cardiac dilatation in human pathologies like viral myocarditis and puerperal cardiomyopathy.
  • Understanding collagen matrix dynamics is critical for addressing heart failure associated with cardiac dilatation.